| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/11/2011 | WO2011070358A3 Systemic administration of an agent that permeabilises tumour vasculature |
| 08/11/2011 | WO2011013003A3 Intranasal granisetron and nasal applicator |
| 08/11/2011 | WO2011008823A9 Peptide-mediated non-covalent delivery of active agents across the blood brain barrier |
| 08/11/2011 | WO2006058249A3 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 08/11/2011 | US20110195865 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
| 08/11/2011 | US20110195030 Nanoparticle compositions comprising liquid oil cores |
| 08/11/2011 | US20110195029 Fluorescent emulsion |
| 08/11/2011 | US20110195028 Magnetic resonance imaging and/or spectroscopy contrast agents and methods of use thereof |
| 08/11/2011 | US20110195027 Cd9-specific human antibodies |
| 08/11/2011 | US20110195026 Protein |
| 08/11/2011 | US20110195025 Anionic oligosaccharide conjugates |
| 08/11/2011 | US20110195024 Isatin derivatives for use as in vivo imaging agents |
| 08/11/2011 | US20110195022 Cd20 antibodies and uses thereof |
| 08/11/2011 | US20110195021 Cd20 antibodies and uses thereof |
| 08/11/2011 | US20110195019 Nucleic acids and corresponding proteins entitled 251p5g2 useful in treatment and detection of cancer |
| 08/11/2011 | US20110195018 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists |
| 08/11/2011 | CA2788736A1 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis |
| 08/10/2011 | EP2354149A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/10/2011 | EP2352455A1 Method and device for marking a medium, and marker usable in such a method |
| 08/10/2011 | EP2029754B1 Magnetosome gene expression in eukaryotic cells |
| 08/10/2011 | EP1747277B1 Gene delivery to neuronal cells |
| 08/10/2011 | EP1509617B1 Light emitting microorganisms and viruses for diagnosis of diseases associated with wounded or inflamed tissue |
| 08/10/2011 | EP1469890B1 Responsive paramagnetic mri contrast agents |
| 08/10/2011 | CN102149414A Drug carrier providing MRI contrast enhancement |
| 08/10/2011 | CN102149413A Method for determining the anti-tumor efficacy of monoclonal antibodies |
| 08/10/2011 | CN102149371A Chelating amphiphilic polymers |
| 08/10/2011 | CN102145183A Method for preparing nanogate carbon suspension |
| 08/10/2011 | CN102145182A Method for detecting medicine cardiotoxicity |
| 08/10/2011 | CN101711881B Gadolinium-containing macromolecule magnetic resonance intravascular contrast medium and preparation method thereof |
| 08/10/2011 | CN101626725B Arrangement for magnetic particle imaging, method for influencing and/or detecting magnetic particles and magnetic particle |
| 08/09/2011 | US7994288 Allergenic proteins of natural rubber latex, their production and use in assays |
| 08/09/2011 | US7994258 Hyperbranched polymer having nitroxyl group |
| 08/09/2011 | US7994134 Peptide-based compounds |
| 08/09/2011 | US7993635 Menthol-containing formulation |
| 08/09/2011 | US7993628 Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure |
| 08/09/2011 | US7993627 Using immunoassy to screen moulators of brain protein expression in cells; treating Alzheimer's disease/brain disorders; drug screening |
| 08/09/2011 | CA2441146C Fluorescent cobalamins and uses thereof |
| 08/09/2011 | CA2253240C Hereditary hemochromatosis gene |
| 08/09/2011 | CA2146328C C-c ckr-1, c-c chemokine receptor |
| 08/04/2011 | WO2011094352A1 In-vivo non-viral gene delivery of human vascular endothelial growth factor following islet transplantation |
| 08/04/2011 | WO2011093098A1 Novel indocyanine compound, synthesis method thereof, purification method thereof, diagnostic composition using indocyanine compound, and device for measuring in vivo kinetics and device for visualizing circulation using diagnostic composition |
| 08/04/2011 | WO2011031999A3 Multi-component nanoparticle structure having detectable magnetic resonance properties |
| 08/04/2011 | WO2011031073A3 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof |
| 08/04/2011 | WO2010061386A3 Pharmaceutical composition and system for permeabilizing fetal membranes |
| 08/04/2011 | US20110191869 Method For Characterising The Biological Activity Of Helminth Eggs, In Particular Trichuris Eggs |
| 08/04/2011 | US20110190728 Dye solution |
| 08/04/2011 | US20110190623 Thermally-activatable liposome compositions and methods for imaging, diagnosis and therapy |
| 08/04/2011 | US20110189177 Antibodies to vla-1 |
| 08/04/2011 | US20110189101 Fluorescent labeling agent and fluorescent labeling method |
| 08/04/2011 | US20110189100 Bone substitute containing a contrast agent, method for preparing same and uses thereof |
| 08/04/2011 | US20110189099 Attenuated mycoplasma gallisepticum strains |
| 08/04/2011 | US20110189098 Therapy delivery and monitoring using a gene of interest-reporter fusion protein and optical imaging |
| 08/04/2011 | US20110189097 Use of WNT inhibitor to inhibit angiogenesis in the CNS |
| 08/04/2011 | US20110189096 Central nervous system tissue-labeling composition, method for labeling central nervous system tissue, and screening method using central nervous system tissue-labeling composition |
| 08/04/2011 | US20110189095 Crkl targeting peptides |
| 08/04/2011 | US20110189094 Biological method for in vivo tracking of molecules affecting cellular migration |
| 08/04/2011 | US20110189093 Prostate specific membrane antigen antibodies and antigen binding fragments |
| 08/04/2011 | US20110189092 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 08/04/2011 | US20110189091 Colon lavage system |
| 08/04/2011 | US20110189090 Molecular probes for imaging of myelin |
| 08/04/2011 | US20110189086 Diagnostic Method for Atherosclerosis |
| 08/03/2011 | EP2351844A1 Compositions for enhancing transport and antisense efficacy of nucleic acid analog into cells |
| 08/03/2011 | EP2351777A1 Anti-muc1 antibody |
| 08/03/2011 | EP2350294A2 Models of thrombotic thrombocytopenic purpura and methods of use thereof |
| 08/03/2011 | EP2350112A2 Site-specific n-terminal modifications of proteins and conjugate formation |
| 08/03/2011 | EP2349350A1 A process for the preparation of aqueous solutions of hyperpolarized molecules |
| 08/03/2011 | EP2349349A1 Diagnostic and/or therapeutic agent, method for the manufacture thereof and use thereof |
| 08/03/2011 | EP2348983A1 Detection of cancer |
| 08/03/2011 | CN102143764A Nanocrystal nano-emulsion |
| 08/03/2011 | CN102143763A Fluorescent emulsion of indocyanine green |
| 08/03/2011 | CN102139118A Isosmotic gastrointestinal tract neutral filling liquid for CT (computed tomography), MR (magnetic resonance), PET (positron emission tomography)/CT |
| 08/03/2011 | CN102138889A Targeted drug-bearing ultrasonic microbubble and preparation method thereof |
| 08/02/2011 | US7989593 Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof |
| 08/02/2011 | US7989503 Smooth muscle peristole inhibitor |
| 08/02/2011 | US7988980 Tuberculosis vaccine with improved efficacy |
| 08/02/2011 | US7988977 Modified live Aeromonas hydrophila vaccine for aquatic animals |
| 08/02/2011 | US7988951 Method for inducing selectively suppressed immune response to transplanted tissue or cells |
| 08/02/2011 | US7988950 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents |
| 08/02/2011 | CA2475395C Anti-human tenascin monoclonal antibody |
| 08/02/2011 | CA2419420C Thioflavin derivatives for use in antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 07/28/2011 | WO2011091113A2 Detection of early-stage pancreatic adenocarcinoma |
| 07/28/2011 | WO2011090349A2 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties |
| 07/28/2011 | WO2011088571A1 Device, system and method for quantifying fluorescence and optical properties |
| 07/28/2011 | WO2008137733A3 Micellar structures, methods of making micellar structures, methods of imaging, and methods of delivering agents |
| 07/28/2011 | US20110184293 Device, method and kit for in vivo detection of a biomarker |
| 07/28/2011 | US20110182827 Method and Dosage Form to Confirm Compliant Use of a Bioactive Agent |
| 07/28/2011 | US20110182825 Methods and devices for assessment of mitochondrial function |
| 07/28/2011 | US20110182824 Method and dosage form to confirm compliant use of a bioactive agent |
| 07/28/2011 | US20110182823 Compositions and methods for in vivo evaluation of bioluminescence |
| 07/28/2011 | US20110182822 Biomarkers for Painful Intervertebral Discs and Methods of Use Thereof |
| 07/28/2011 | US20110182821 Clustered magnetic particles as tracers for magnetic particle imaging |
| 07/28/2011 | US20110182820 Methods for the prediction of short-term and long-term cognitive decline in alzheimer's disease patients using csf biomarkers |
| 07/28/2011 | US20110182819 Methods and Compounds for Promoting Vessel Regression |
| 07/28/2011 | US20110182818 Methods and compositions for the treatment of symptoms of neurological and mental health disorders |
| 07/28/2011 | US20110182817 Antibody against calcified globule and use of the same |
| 07/28/2011 | US20110182816 ANTIBODY AGAINST OXIDIZED LDL/ß2GPI COMPLEX AND USE OF THE SAME |
| 07/28/2011 | US20110182815 Method for the detection of enzymatic activity with magnetically functionalized substrates |
| 07/28/2011 | US20110182814 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma |
| 07/28/2011 | US20110182813 Amphiphilic copolymers and compositions containing such polymers |
| 07/28/2011 | US20110182812 Imaging Agents for Detecting Neurological Disorders |